Genmab
GMAB
GMAB
291 hedge funds and large institutions have $2.26B invested in Genmab in 2025 Q4 according to their latest regulatory filings, with 76 funds opening new positions, 123 increasing their positions, 53 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
15% more funds holding
Funds holding: 252 → 291 (+39)
1.77% more ownership
Funds ownership: 9.64% → 11.41% (+1.8%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
291
Holding in Top 10
2
Calls
$3.33M
Puts
$2.54M
Top Buyers
| 1 | +$104M | |
| 2 | +$100M | |
| 3 | +$41.6M | |
| 4 |
BlackRock
New York
|
+$35.6M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
+$34.2M |
Top Sellers
| 1 | -$53M | |
| 2 | -$34.1M | |
| 3 | -$15.4M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$14.8M |
| 5 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$11.9M |
